Patents by Inventor William Muldoon

William Muldoon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9405518
    Abstract: An apparatus of one embodiment translates computer code from a first programming language to a second programming language. The apparatus includes an interface, a memory, and a processor. The interface is operable to receive a compiler output that is associated with source code written in a first programming language. The memory is operable to store the compiler output. The processor is communicatively coupled to the interface and the memory and is operable to analyze the data structures within the compiler output, build an internal representation of the source code based on the compiler output, and create a source code template associated with a second programming language.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: August 2, 2016
    Assignee: Bank of America Corporation
    Inventor: William Muldoon
  • Publication number: 20160132307
    Abstract: An apparatus of one embodiment translates computer code from a first programming language to a second programming language. The apparatus includes an interface, a memory, and a processor. The interface is operable to receive a compiler output that is associated with source code written in a first programming language. The memory is operable to store the compiler output. The processor is communicatively coupled to the interface and the memory and is operable to analyze the data structures within the compiler output, build an internal representation of the source code based on the compiler output, and create a source code template associated with a second programming language.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 12, 2016
    Inventor: William Muldoon
  • Publication number: 20160132308
    Abstract: An apparatus of one embodiment translates computer code from a first programming language to a second programming language. The apparatus includes an interface, a memory, and a processor. The interface is operable to receive a compiler output that is associated with source code written in a first programming language. The memory is operable to store the compiler output. The processor is communicatively coupled to the interface and the memory and is operable to analyze the data structures within the compiler output, build an internal representation of the source code based on the compiler output, and create a source code template associated with a second programming language.
    Type: Application
    Filed: January 11, 2016
    Publication date: May 12, 2016
    Inventor: William Muldoon
  • Patent number: 9317266
    Abstract: An apparatus of one embodiment translates computer code from a first programming language to a second programming language. The apparatus includes an interface, a memory, and a processor. The interface is operable to receive a compiler output that is associated with source code written in a first programming language. The memory is operable to store the compiler output. The processor is communicatively coupled to the interface and the memory and is operable to analyze the data structures within the compiler output, build an internal representation of the source code based on the compiler output, and create a source code template associated with a second programming language.
    Type: Grant
    Filed: November 12, 2014
    Date of Patent: April 19, 2016
    Assignee: Bank of America Corporation
    Inventor: William Muldoon
  • Publication number: 20070281023
    Abstract: A pharmaceutical composition which composition comprises an insulin sensitiser and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of the insulin sensitiser and the use of such composition in medicine.
    Type: Application
    Filed: August 15, 2007
    Publication date: December 6, 2007
    Inventors: Robert GLINECKE, Susan Milosovich, William Muldoon, Vincenzo Re, Joseph Sauer, Janet Skinner
  • Publication number: 20050136111
    Abstract: A pharmaceutical composition which composition comprises an insulin sensitiser and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of the insulin sensitiser and the use of such composition in medicine.
    Type: Application
    Filed: January 26, 2005
    Publication date: June 23, 2005
    Inventors: Robert Glinecke, Susan Milosovich, William Muldoon, Vincenzo Re, Joseph Sauer, Janet Skinner
  • Publication number: 20040091531
    Abstract: A pharmaceutical composition which composition comprises an insulin sensitiser and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of the insulin sensitiser and the use of such composition in medicine.
    Type: Application
    Filed: November 5, 2003
    Publication date: May 13, 2004
    Applicants: SmithKline Beecham p.l.c., SmithKline Beecham Corporation
    Inventors: Robert Glinecke, Susan Marie Milosovich, William Muldoon, Vincenzo Re, Joseph Sauer, Janet Louise Skinner
  • Publication number: 20030153607
    Abstract: A pharmaceutical composition which composition comprises an insulin sensitiser and a pharmaceutically acceptable carrier therefor, wherein the composition is arranged to provide a modified release of the insulin sensitiser and the use of such composition in medicine.
    Type: Application
    Filed: February 26, 2003
    Publication date: August 14, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: Robert Glinecke, Susan Marie Milosovich, William Muldoon, Vincenzo Re, Joseph Sauer, Janet Louise Skinner
  • Patent number: 6451343
    Abstract: Controlled release dosage forms useful in the treatment and/or prophylaxis of dementia, including Alzheimer's disease, in mammals, and for enhancing amyloid precursor protein processing along a non-amyloidogenic pathway in patients suffering from, or at risk of developing, Alzeimer's disease.
    Type: Grant
    Filed: August 30, 2000
    Date of Patent: September 17, 2002
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventors: Robert Glinecke, William Muldoon, Susan Marie Milosovich, Joseph Sauer, Laurence Rousseau